Clinical Trials Sponsored by Jason Baker

Total 2594 results

Bayer

Completed

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

Contraception

Netherlands, Germany
Bayer

Completed

A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

Pneumonia

Italy
Bayer

Completed

Hepatic Impairment Study

Liver Disease

United States
Bayer

Completed

BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma

Carcinoma, Renal Cell

Russian Federation, France, United States, Germany, Poland, Ukraine, United Kingdom
Bayer

Completed

Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.

Atrial Fibrillation

Germany
Bayer

Completed

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (ODIXaHIP-OD)

Venous Thromboembolism

Italy, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, Norway, United Kingdom, France
Bayer

Completed

Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Venous Thromboembolism

Italy, Spain, Poland, United States, Czech Republic, Canada, Denmark, Netherlands, Belgium, Chile, Slovakia, Hungary, Austria, France, Germany, South Africa, Sweden, Turkey, Colombia, Israel, Mexico, Argentina, Norway, Brazil, Lithuania, ... and more
Bayer

Completed

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

Contraception

France, Italy, Spain, Germany, United Kingdom
Bayer

Completed

Copanlisib Mass Balance Study

Healthy Volunteers

Netherlands
Bayer

Completed

Special Drug Use Investigation of Glucobay OD

Diabetes Mellitus

Japan
Bayer

Completed

Validation Study for Endometriosis PRO (VALEPRO)

Endometriosis

United States, Germany
Bayer

Completed

ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer

Metastatic Breast Cancer

Spain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
Bayer

Completed

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration (REVIEW)

Macular Degeneration

Portugal
Bayer

Terminated

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors

Neoplasms

Netherlands
Bayer

Completed

Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging

Magnetic Resonance Imaging

Japan
Bayer

Completed

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

Vasomotor Symptoms

China
Bayer

Completed

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Fibrosis | Renal Insufficiency | Kidney Failure

United States
Bayer

Completed

A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease

Pelvic Inflammatory Disease

China, Philippines, Thailand, Pakistan, Taiwan, Indonesia, Korea, Republic of
Bayer

Completed

Compare Pharmacokinetic (PK) Profiles of Naproxen Sodium, Diphenhydramine Hydrochloride, and Naproxen Sodium and Diphenhydramine Hydrochloride Combination (Morpheus PK)

Therapeutic Equivalence

United States
Bayer

Completed

Kogenate FS Regulatory Post-Marketing Surveillance (KG0910KR)

Hemophilia A

Korea, Republic of
Bayer

Completed

Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis (Phoenix II)

Dermatitis, Atopic

Germany
Bayer

Completed

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

Pharmacokinetics

United States
Bayer

Completed

Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being (COSME)

Contraception

Italy
Bayer

Completed

Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton

Prostate Cancer | Pharmacokinetics | Metastases

United States
Bayer

Completed

Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding

Menorrhagia

Italy
Bayer

Completed

Bioequivalence Study of BAY77-1931 Granule

Hyperphosphatemia

Japan
Bayer

Completed

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

Neoplasms

United States
Bayer

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Hyperphosphatemia | Dialysis

Japan
Bayer

Completed

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator (DIGIT)

Raynaud Disease

Germany
Bayer

Completed

Myocardial Perfusion MRI

Magnetic Resonance Imaging | Myocardial Perfusion Imaging

Switzerland, Germany, Austria, Poland
Bayer

Completed

Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan

Pharmacokinetics

United States
Bayer

Terminated

Real Life Safety and Efficacy of Vardenafil

Erectile Dysfunction

Taiwan
Bayer

Completed

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

Pharmacokinetics

United States
Bayer

Completed

Single/Multiple Dose Bioavailability Trial

Healthy

United States
Bayer

Completed

Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)

Carcinoma, Renal Cell

China, Taiwan
Bayer

Completed

A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Belgium, Israel, Italy, France, United States
Bayer

Completed

Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder

Pulmonary Disease, Chronic Obstructive | Infection

Germany
Bayer

Completed

Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)

Male | Androgens (Deficiency)

Italy, Spain, Austria, Finland, United Kingdom, Germany, Ireland, Sweden
Bayer

Completed

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Multiple Sclerosis | Positron-Emission Tomography

Australia, Sweden
Bayer

Completed

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

Contraception | Ovulation Inhibition | Contraceptives, Oral

United States
Bayer

Completed

Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging

Central Nervous System Diseases

Korea, Republic of, United States, Colombia, China, Argentina
Bayer

Completed

Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Brain Diseases | Spinal Cord Diseases

United States, Colombia, Argentina, Brazil
Bayer

Completed

Acceptability of Long-term Progestin-only Contraception in Europe

Contraception

Slovakia, France, United Kingdom, Ireland
Bayer

Completed

Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)

Carcinoma, Hepatocellular

Korea, Republic of, Japan
Bayer

Completed

Long-term Extension From RCC Phase II (11515)

Carcinoma, Renal Cell

Japan
Bayer

Completed

BAY43-9006 - Phase II in Advanced Breast Cancer

Breast Cancer | Breast Neoplasms

Italy, Germany
Bayer

Completed

A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings

Menorrhagia

Sweden
Bayer

Completed

Angeliq Regulatory Post Marketing Surveillance (Angeliq rPMS)

Osteoporosis, Postmenopausal | Postmenopausal Period

Korea, Republic of
Bayer

Completed

Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung | Lung Cancer

United States
Bayer

Withdrawn

Coronary Vasomotor Response After Riociguat Exposure (CORONARIES)

Coronary Artery Disease

United States

3

Subscribe